scispace - formally typeset
L

Lewis L. Lanier

Researcher at University of California, San Francisco

Publications -  576
Citations -  93495

Lewis L. Lanier is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Interleukin 21 & Natural killer cell. The author has an hindex of 159, co-authored 554 publications receiving 86677 citations. Previous affiliations of Lewis L. Lanier include University of Rome Tor Vergata & Cancer Research Institute.

Papers
More filters
Journal ArticleDOI

Tolerance to non-H-2 histocompatibility antigens. Transplantation tolerance to the H-4 and H-7 histocompatibility antigens.

TL;DR: Results suggest that tolerance involving the H-4 and H-7 antigens is most likely because of a clonal inactivation of alloantigen-reactive cells as a consequence of neonatal exposure to antigen.
Patent

Gp98 cell adhesion molecule and integrin complex containing it.

TL;DR: A purified integrin glycoprotein complex (cell adhesion molecule) is provided in this paper composed of beta 4, alpha 6, and a novel 98 kD subunit (gp98).
Patent

MDL-1 polypeptides

TL;DR: In this paper, the purification and isolation of various genes which encode mammalian cell surface polypeptides is discussed. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.